Bayesian Capital Management’s Ameren AEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,385
Closed -$771K 121
2025
Q3
$771K Buy
+7,385
New +$737K 0.16% 202
2025
Q2
Sell
-3,000
Closed -$301K 516
2025
Q1
$301K Buy
+3,000
New +$289K 0.05% 387
2024
Q4
Sell
-18,700
Closed -$1.64M 658
2024
Q3
$1.64M Buy
18,700
+13,200
+240% +$1.06M 0.19% 160
2024
Q2
$391K Buy
5,500
+1,000
+22% +$72.7K 0.04% 433
2024
Q1
$333K Buy
+4,500
New +$320K 0.03% 534
2023
Q2
Sell
-18,100
Closed -$1.56M 758
2023
Q1
$1.56M Buy
+18,100
New +$1.55M 0.19% 153
2021
Q3
Sell
-3,043
Closed -$244K 368
2021
Q2
$244K Buy
+3,043
New +$255K 0.06% 332
2020
Q2
Sell
-4,864
Closed -$354K 506
2020
Q1
$354K Buy
+4,864
New +$386K 0.08% 397
2018
Q4
Sell
-10,000
Closed -$632K 594
2018
Q3
$632K Buy
+10,000
New +$630K 0.1% 273

Other funds holding AEE

Bayesian Capital Management's AEE Position: Q4 2025 in Review

Bayesian Capital Management sold out of Ameren (AEE) in Q4 2025, closing a stake of 7,385 shares — an estimated $771K sold.

Bayesian Capital Management first reported a position in AEE in Q3 2018 and held it in 9 quarters. The position peaked at $1.64M in Q3 2024. 880 funds tracked by Wall St. Rank hold AEE as of Q4 2025.

  • Bayesian Capital Management reported no remaining Ameren position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 7,385 Ameren shares in Q4 2025, an estimated $771K.
  • Bayesian Capital Management first reported a position in Ameren in Q3 2018 and held it in 9 quarters.
  • Bayesian Capital Management's Ameren position peaked at $1.64M in Q3 2024.
  • 880 funds tracked by Wall St. Rank held Ameren as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.